CLB - Core Laboratories NV - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: NL0000200384

Laboratory, Analytical, Testing, Services, Reservoir, Enhancement, Products

Core Laboratories NV is a leading provider of innovative solutions to the oil and gas industry, operating in the United States and internationally. The company's primary objective is to help its clients optimize their reservoir performance, increase hydrocarbon recovery, and reduce operational costs.

The Reservoir Description segment is a critical component of Core Laboratories' business, focusing on the detailed analysis of petroleum reservoir rock and fluid samples. This involves a range of laboratory-based analytical and field services, including the characterization of crude oil and oil products, as well as proprietary and joint industry studies. These services enable clients to better understand their reservoirs, identify opportunities for improvement, and develop effective strategies for enhanced oil recovery. Additionally, the company provides support for carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities.

The Production Enhancement segment offers a comprehensive suite of services and products designed to optimize well performance and improve hydrocarbon recovery. This includes integrated diagnostic services to evaluate and monitor well completions, as well as solutions to enhance the effectiveness of enhanced oil recovery projects. The company's expertise in reservoir well completions, perforations, stimulations, production, and well abandonment enables clients to maximize their returns on investment and minimize operational risks.

Core Laboratories' commitment to innovation and customer service is reflected in its marketing and sales strategy, which combines the efforts of sales representatives, technical seminars, trade shows, and print advertising. The company also partners with distributors to ensure its products and services are accessible to clients worldwide. With a rich history dating back to 1936, Core Laboratories is headquartered in Houston, Texas, and continues to be a trusted partner to the oil and gas industry. For more information, visit https://www.corelab.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for CLB - Core Laboratories NV  - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for CLB - Core Laboratories NV  - Stock & Dividends

CLB Stock Overview

Market Cap in USD 863m
Sector Energy
Industry Oil & Gas Equipment & Services
GiC SubIndustry Oil & Gas Equipment & Services
TER 0.00%
IPO / Inception 1995-09-20

CLB Stock Ratings

Growth 5y -36.5
Fundamental 10.5
Dividend 9.06
Rel. Performance vs Sector -2.63
Analysts 2.57/5
Fair Price Momentum 15.74 USD
Fair Price DCF 15.47 USD

CLB Dividends

Dividend Yield 12m 0.21%
Yield on Cost 5y 0.09%
Dividends CAGR 5y -55.13%
Payout Consistency 86.6%

CLB Growth Ratios

Growth 12m -18.67%
Growth Correlation 12m 33.9%
Growth Correlation 3m -49.9%
CAGR 5y -15.61%
CAGR/Mean DD 5y -0.31
Sharpe Ratio 12m -0.60
Alpha vs SP500 12m -73.71
Beta vs SP500 5y weekly 1.40
ValueRay RSI 46.63
Volatility GJR Garch 1y 37.95%
Price / SMA 50 -0.05%
Price / SMA 200 3.73%
Current Volume 270k
Average Volume 20d 289.8k

External Links for CLB Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of CLB stocks?
As of October 22, 2024, the stock is trading at USD 18.63 with a total of 270,015 shares traded.
Over the past week, the price has changed by -1.95%, over one month by +0.27%, over three months by -17.64% and over the past year by -19.41%.
What are the forecast for CLB stock price target?
According to ValueRays Forecast Model, CLB Core Laboratories NV will be worth about 17.5 in October 2025. The stock is currently trading at 18.63. This means that the stock has a potential downside of -6.12%.
Issuer Forecast Upside
Wallstreet Target Price 20 7.35
Analysts Target Price 23.3 24.8
ValueRay Target Price 17.5 -6.12